Topical treatment with imiquimod may induce regression of facial keratoacanthoma

European Journal of Dermatology

Volumn 13, Issue 1, 2003, Pages 80-82

  Dendorfer, Markus ^a   Oppel, Tilmann ^a   Wollenberg, Andreas ^a   Prinz, Jörg Christoph ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Imiquimod; Immunomodulation; Keratoacanthoma

Indexed keywords

IMIQUIMOD;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; CONTROLLED STUDY; CREAM; DRUG EFFECT; FACE TUMOR; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOSTIMULATION; KERATOACANTHOMA; MALE; NOSE TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR IMMUNITY; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; FACIAL DERMATOSES; FEMALE; HUMANS; KERATOACANTHOMA; MALE; MIDDLE AGED;

EID: 0037285862     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Patel A, Halliday GM, Cooke BE, Barnetson RS. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131: 789-98.
2. Ramselaar CG, van der Meer JB. The spontaneous regression of keratoacanthoma in man. Acta Dermatovener 1976; 56: 245-51.
3. Nedwich JA. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma. Australas J Dermatol 1991; 32: 137-41.
4. Donahue B, Cooper JS, Rush S. Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 1990; 23: 489-93.
5. Goette DG, Odom RB. Successful treatment of keratoacanthoma with intralesional fluorouracil. J Am Acad Dermatol 1980; 2: 212-6.
6. Melton JL, Nelson BR, Stough DB, Brown MD, Swanson NA, Johnson TM. Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 1991; 25: 1017-23.
7. Grob JJ, Suzini F, Richard MA, Weiller M, Zarour H, Noe C, Munoz MH, Bonerandi JJ. Large keratoacanthomas treated with intralesional interferon alpha-2a. J Am Acad Dermatol 1993; 29: 237-41.
8. Santosa Pham JC, Shelley ED, Shelley WB. Aggressive giant keratoacanthoma of the face treated with intromusculor methotrexate ond triomcinolone acetonide. Cutis 1997; 59: 329-32.
9. Hannuksela-Svahn A, Nordal E, Christensen OB. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream. Acta Derm Venereol 2000; 80: 381-2.
10. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: o report of six cases. Br J Dermatol 2001; 144: 1050-3.
11. Wigbels B, Luger T, Metze D. Imiquimod: o new treotment possibility in bowenoid papulosis? Hautarzt 2001; 52: 128-32.
12. Slade HB. Cytokine induction and modifying the immune response to human papillomo virus with imiquimod. Eur J Dermatol 1998; 8: 13-6.
13. Kono T, Kondo S, Postore S, Shivji GM, Tomai MA, McKenzie RC, Sauder DN. Effects of a noval topical immunomodulotor, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res 1994; 13: 71-6.
14. Testerman TC, Gerster JF, Imbertson LM, Reiter MJ, Miller RC, Gibson SJ, Wager TC Tomai TH. Cytokine induction by the immunomodulators imiquimod ond S-27609. J Leukoc Biol 1995; 58: 365-72.
15. Halliday GM, Patel A, Hunt MJ, Tefany FJ, Barnetson RS. Spontaneous regression of human melanomo/nonmelanomo skin concer: association with infiltrating CD4+ T cells. World J Surg 1995; 19: 352-8.